Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
June 18, 2024 08:00 ET
|
Assembly Biosciences, Inc.
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases,...
Plant Extracts Global Strategic Business Report 2023-2024 & 2030
June 17, 2024 10:20 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Plant Extracts - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Plant Extracts is...
Assembly Biosciences Announces $12.6 Million in Equity Financings
June 17, 2024 08:00 ET
|
Assembly Biosciences, Inc.
— Funding supports advancement of antiviral portfolio, including four candidates in clinical development, and extends cash runway into Q1 2026 — — Anticipated near term interim data read outs include...
Correction: Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groundbreaking Nimvec™ AM510 gene therapy against Type 1 Diabetes
June 17, 2024 05:39 ET
|
Amarna Therapeutics
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groundbreaking Nimvec™ AM510 gene therapy against Type 1...
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groundbreaking Nimvec™ AM510 gene therapy against Type 1 Diabetes
June 17, 2024 05:23 ET
|
Amarna Therapeutics
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groundbreaking Nimvec™ AM510 gene therapy against Type 1...
$842.7 Million SDS Poly Acrylamide Gel Electrophoresis Market Forecast, 2030 - Featuring Profiles of 13 Companies Including Abcam, Bio-Rad Laboratories, GE Healthcare, and Thermo Fisher Scientific
June 17, 2024 04:18 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "SDS Poly Acrylamide Gel Electrophoresis - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective and Surpassed Standard of Care in Treating Hard-to-Treat T-ALL/LBL; Data Presented Today at European Hematology Association (EHA) 2024 Hybrid Congress
June 14, 2024 07:30 ET
|
Wugen
Wugen Presents Data at European Hematology Association (EHA) 2024 Hybrid Congress
Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ET
June 13, 2024 10:13 ET
|
Pressure BioSciences, Inc.
Pressure BioSciences, Inc. to Host Business and Financial Update
Investor Call on Wednesday, June 19th at 4:30pm ET
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
June 12, 2024 16:01 ET
|
Barinthus Biotherapeutics
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
Investment Opportunity: PlantForm Corporation Seeks $25M to Accelerate Plant-Based Medical Breakthroughs
June 12, 2024 14:40 ET
|
US Capital Global
San Francisco, California, USA, June 12, 2024 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an SEC-registered affiliate of renowned global financial group US Capital Global, is pleased to...